Osteoporosis
Effects of progestogen-only contraceptive drugs on bone mineral density are reviewed
Published in Medical Letter on the CDC and FDA, July 2nd, 2006
According to the reviewers, "Questions have been raised about the effects of progestogen-only contraceptive use on bone health, particularly among young women who have not yet reached peak bone mass and perimenopausal women who may be starting to lose bone mass. We conducted a systematic review that evaluated the association between progestogen-only contraceptive use and fracture risk or bone mineral density (BMD)."
"We identified 39 articles from MEDLINE and EMBASE, published through July 2005," said Kathryn...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Disease Control
Pediatric pneumococcal vaccination decreases adult Streptococcus pneumoniae - Drug Safety
Allometric methods to predict drug clearance in children are compared - Information Technology
Health survey estimates are impacted by substitution of cell phones for land lines - Public Health
Delayed childbearing may contribute to trend in low birthweight rates - Adverse Drug Reaction
Clinical features of gemcitabine-associated lung injury are described - Adverse Drug Reaction
Severe serum sickness reaction to oral and intramuscular penicillin is reported - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
